Pretreatment and Routine Echocardiogram Monitoring During Chemotherapy for Anthracycline-Induced Cardiotoxicity Rarely Identifies Significant Cardiac Dysfunction or Alters Treatment Decisions: A 5-Year Review at a Single Pediatric Oncology Center

The widespread use of anthracycline chemotherapy has contributed to improved outcomes in children with cancer. The most feared complication of the anthracyclines is cardiotoxicity. Routine echocardiographic monitoring typically is used before, during, and after treatment to minimize cardiotoxicity....

Ausführliche Beschreibung